Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesus Prieto

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Cardiovascular Research|February 10, 2015
Sphingosylphosphorylcholine potentiates vasoreactivity and voltage-gated Ca2+ entry via NOX1 and reactive oxygen speciesYasin Shaifta, Vladimir A Snetkov, Jesus Prieto-Lloret, et al.
Advances in Experimental Medicine and Biology|June 15, 2023
Effect of Carotid Body Denervation on Systemic Endothelial Function in a Diabetic Animal ModelMarlene D Cabral, Fátima O Martins, Inês B Martins, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected liversMyriam Vilasco, Esther Larrea, Damien Vitour, et al.
Human Gene Therapy. Clinical Development|March 14, 2017
Improvement of Adeno-Associated Virus-Mediated Liver Transduction Efficacy by Regional Administration in Macaca fascicularisNerea Zabaleta, David Salas, Maria Paramo, et al.
Plos One|July 12, 2013
IL12-mediated liver inflammation reduces the formation of AAV transcriptionally active forms but has no effect over preexisting AAV transgene expressionIrene Gil-Fariña, Marianna Di Scala, Lucia Vanrell, et al.
Plos One|March 24, 2016
A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and SignalingEstanislao Nistal-Villan, Joanna Poutou, Estefania Rodríguez-Garcia, et al.
Gut|June 22, 2013
Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytesEsther Larrea, Jose-I Riezu-Boj, Rafael Aldabe, et al.
Gastroenterology|April 3, 2003
A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosisJuan-Felipe Lucena, J Ignacio Herrero, Jorge Quiroga, et al.
Cancer Research|November 15, 2012
Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion proteinMaria C Ochoa, Jessica Fioravanti, Inmaculada Rodriguez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2016
Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and PatientsIrene Gil-Farina, Raffaele Fronza, Christine Kaeppel, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Cardiovascular Research|February 10, 2015
Sphingosylphosphorylcholine potentiates vasoreactivity and voltage-gated Ca2+ entry via NOX1 and reactive oxygen speciesYasin Shaifta, Vladimir A Snetkov, Jesus Prieto-Lloret, et al.
Advances in Experimental Medicine and Biology|June 15, 2023
Effect of Carotid Body Denervation on Systemic Endothelial Function in a Diabetic Animal ModelMarlene D Cabral, Fátima O Martins, Inês B Martins, et al.
Hepatology (Baltimore, Md.)|November 30, 2006
The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected liversMyriam Vilasco, Esther Larrea, Damien Vitour, et al.
Human Gene Therapy. Clinical Development|March 14, 2017
Improvement of Adeno-Associated Virus-Mediated Liver Transduction Efficacy by Regional Administration in Macaca fascicularisNerea Zabaleta, David Salas, Maria Paramo, et al.
Plos One|July 12, 2013
IL12-mediated liver inflammation reduces the formation of AAV transcriptionally active forms but has no effect over preexisting AAV transgene expressionIrene Gil-Fariña, Marianna Di Scala, Lucia Vanrell, et al.
Plos One|March 24, 2016
A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and SignalingEstanislao Nistal-Villan, Joanna Poutou, Estefania Rodríguez-Garcia, et al.
Gut|June 22, 2013
Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytesEsther Larrea, Jose-I Riezu-Boj, Rafael Aldabe, et al.
Gastroenterology|April 3, 2003
A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosisJuan-Felipe Lucena, J Ignacio Herrero, Jorge Quiroga, et al.
Cancer Research|November 15, 2012
Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion proteinMaria C Ochoa, Jessica Fioravanti, Inmaculada Rodriguez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2016
Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and PatientsIrene Gil-Farina, Raffaele Fronza, Christine Kaeppel, et al.
Pageof 14